Financhill
Buy
66

CLS Quote, Financials, Valuation and Earnings

Last price:
$119.27
Seasonality move :
4.34%
Day range:
$118.60 - $130.21
52-week range:
$40.02 - $144.27
Dividend yield:
0%
P/E ratio:
31.89x
P/S ratio:
1.47x
P/B ratio:
7.30x
Volume:
4.4M
Avg. volume:
5.2M
1-year change:
220.56%
Market cap:
$13.8B
Revenue:
$9.6B
EPS (TTM):
$3.74

Earnings Data

Next earnings date for CLS
Apr 24
2025
Most recent earnings per share
$1.29
Beat by $0.23
(Jan 29/2025)
Consensus Estimate
$1.06
(Jan 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/24/2025 Q1 $2.6B -- -- $1.11 --
01/29/2025 Q4 $2.5B $2.5B $1.29 $1.06 $0.23
10/23/2024 Q3 $2.4B $2.5B $0.77 $0.94 -$0.17
07/24/2024 Q2 $2.2B $2.4B $0.83 $0.82 $0.01
04/24/2024 Q1 $2.2B $2.2B $0.85 $0.75 $0.10
01/29/2024 Q4 $2.1B $2.1B $0.70 $0.68 $0.02
10/25/2023 Q3 -- -- $0.67 $0.60 $0.07
07/26/2023 Q2 -- -- $0.46 $0.47 -$0.01
04/26/2023 Q1 -- -- $0.20 $0.46 -$0.26
01/25/2023 Q4 -- -- $0.35 $0.54 -$0.19
10/24/2022 Q3 -- -- $0.37 $0.45 -$0.08
07/25/2022 Q2 -- -- $0.29 $0.42 -$0.13
04/27/2022 Q1 -- -- $0.17 $0.35 -$0.18
01/26/2022 Q4 -- -- $0.26 $0.38 -$0.12
10/26/2021 Q3 -- -- $0.28 $0.32 -$0.04
07/26/2021 Q2 -- -- $0.21 $0.24 -$0.03
04/29/2021 Q1 -- -- $0.08 $0.20 -$0.12
01/27/2021 Q4 -- -- $0.16 $0.25 -$0.09
10/28/2020 Q3 -- -- $0.24 $0.25 -$0.01
07/29/2020 Q2 -- -- $0.10 $0.15 -$0.05
04/29/2020 Q1 -- -- -$0.02 $0.11 -$0.13
01/29/2020 Q4 -- -- -$0.05 $0.15 -$0.20
10/24/2019 Q3 -- -- -$0.05 $0.12 -$0.17
07/24/2019 Q2 -- -- $0.12 $0.12 -$0.00
04/25/2019 Q1 -- -- $0.12 $0.16 -$0.04
01/31/2019 Q4 -- -- $0.29 $0.31 -$0.02
10/24/2018 Q3 -- -- $0.26 $0.30 -$0.04
07/31/2018 Q2 -- -- $0.29 $0.28 $0.01
04/27/2018 Q1 -- -- $0.24 $0.24 $0.00
01/24/2018 Q4 -- -- $0.27 $0.30 -$0.03
10/26/2017 Q3 -- -- $0.31 $0.32 -$0.01
07/25/2017 Q2 -- -- $0.32 $0.32 -$0.00
04/20/2017 Q1 -- -- -- $0.22 --
01/26/2017 Q4 -- -- $0.34 $0.28 $0.06
10/20/2016 Q3 -- -- $0.37 $0.22 $0.15
07/21/2016 Q2 -- -- $0.25 $0.18 $0.07
04/21/2016 Q1 -- -- $0.20 $0.14 $0.06
01/27/2016 Q4 -- -- $0.20 $0.25 -$0.05
10/20/2015 Q3 -- -- $0.16 $0.26 -$0.10
07/23/2015 Q2 -- -- $0.21 $0.19 $0.02
04/21/2015 Q1 -- -- $0.12 $0.17 -$0.05

Celestica Earnings Questions

  • How Much did Celestica Generate in Revenue Last Quarter?

    Celestica reported $2.5B worth of top line sales in its most recent quarter.

  • Did Celestica Beat Earnings Last Quarter?

    Celestica announced earnings per share of $1.29 which represents a beat of analyst forecast a $1.06 per share.

  • Is Celestica Profitable?

    Celestica reported $297.2M that represents $2.53 per share over the last quarter.

  • What is the Analyst Consensus for Celestica EPS Next Year?

    Celestica's earnings are forecast to grow from $3.61 per share to $4.83 per share next year representing an increase of 33.77%.

  • When is Celestica's Earnings Date?

    Celestica's next earnings date is April 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will AMD Beat the S&P 500?
Will AMD Beat the S&P 500?

High-performance and adaptive computing leader Advanced Micro Devices (NASDAQ:AMD) is…

Why Did Walmart Stock Fall?
Why Did Walmart Stock Fall?

Walmart (NYSE:WMT) tumbled in spite of strong Q4 results that…

Is Cadence Stock a Buy, Sell or Hold?
Is Cadence Stock a Buy, Sell or Hold?

Cadence Design Systems (NASDAQ:CDNS) has seen its stock move sharply…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Sell
2
GLOB alert for Feb 22

Globant SA [GLOB] is down 27.81% over the past day.

Sell
42
CELH alert for Feb 22

Celsius Holdings [CELH] is up 27.77% over the past day.

Buy
60
HIMS alert for Feb 22

Hims & Hers Health [HIMS] is down 25.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock